NIH associate director announces departure to private sector, joining anti-aging biotech

The associate director of the National Institute of Health’s Office of Legislative Policy and Analysis (OLPA) is leaving her government post to join CEO James Peyer at Cambrian BioPharma. Adrienne Hallett made the announcement via her LinkedIn profile Wednesday morning, linking to a statement from acting NIH director Lawrence Tabak.

Leave a Comment

Your email address will not be published.

Generated by Feedzy